Opioid Use, Abuse and Misuse Resource Center

APhA believes it is imperative that a proper balance be maintained in delivering appropriate pain management for the millions of patients with legitimate needs for controlled substances while taking steps to minimize inappropriate use and abuse.  Pharmacists possess unique knowledge about the safe and effective use of medications and about the adverse events resulting from inappropriate use. Such knowledge enables pharmacists to play an important role in patient access to opioids, but also opioid drug abuse prevention, education, and assistance.  

Opioid News
January 7, 2019
AMA calls on states to remove prior authorization for opioid treatment

Following the news that Pennsylvania will remove prior authorization requirements for medication-assisted treatment (MAT) for opioid-use disorder, the president of the American Medical Association (AMA) called on payers in every state to do the same. “Payers across the nation commonly impose prior-…

Read More
December 11, 2018
Allied Against Opioid Abuse releases toolkit for pharmacists

Pharmacists across the country are turning to resources from the Allied Against Opioid Abuse (AAOA) to help their patients understand the risks and responsibilities of prescription opioids.  AAOA launched in February 2018 as a national coalition and campaign to raise awareness for health care…

Read More
October 24, 2018
APhA, pharmacy groups attend opioid law signing at White House

President Trump invited lawmakers, activists, pharmacy chains, pharmacist groups, and other stakeholders to White House on Wednesday, October 24, 2018, for the signing of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.…

Read More
October 22, 2018
Mandatory PDMP checks may not be beneficial for surgical patients

New data published in JAMA Surgery show that mandating surgeons perform a PDMP query for every postoperative opioid prescription did not decrease the proportion of patients who were given a prescription or the mean number of tablets/capsules prescribed. “PDMP use has been shown by others to…

Read More
September 20, 2018
FDA approves final opioid analgesic REMS, adds immediate-release formulations for outpatient use

  On September 18, FDA approved the final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS). This REMS now includes immediate-release opioid analgesics used in outpatient settings as well as the extended-release and long-acting opioid analgesics that have already been subject to a…

Read More
August 13, 2018
Opioid use disorder skyrockets among pregnant women

  The rate of opioid use disorder (OUD) among women giving birth in hospitals more than quadrupled between 1999 and 2014, from 1.5 cases per 1,000 deliveries to 6.5 cases per 1,000 deliveries, say CDC researchers in the August 10 Morbidity and Mortality Weekly Report.   In their study, researchers…

Read More